Deoxyribonucleic Acid Trip
By Gina Maranto,
New York Times
| 08. 28. 2002
Book review of Gregory Stock,
Redesigning Humans: Our Inevitable
Genetic Future.
GREGORY STOCK has written an enthusiastic book in support of
germ-line manipulations -- that is, making genetic modifications
to eggs, sperm and embryos that can be passed on to future generations.
Like previous explorations of the subject by the ethicist Joseph
F. Fletcher, the lawyer John Robertson and the biologist James
Watson, among others, ''Redesigning Humans: Our Inevitable Genetic
Future'' serves as an apologia for those scientists and physicians
who are already edging toward such work in a piecemeal fashion
in research labs and in vitro fertilization clinics around the
world. It advocates the wholesale adoption of genetic manipulations
with the purpose of finally taking control of human evolution.
This, the author writes, ''is the ultimate expression and realization
of our humanity.''
Because of the breadth of his scientific knowledge and his
considerable flair as a writer, Stock -- who heads the program
on medicine, technology and society at the School of Medicine
of the University of California, Los Angeles -- is a forceful
advocate. First and foremost...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
